Copyright: ©Author(s) 2026.
World J Methodol. Jun 20, 2026; 16(2): 110380
Published online Jun 20, 2026. doi: 10.5662/wjm.v16.i2.110380
Published online Jun 20, 2026. doi: 10.5662/wjm.v16.i2.110380
Figure 1 PRISMA flow diagram of the article selection process.
DOAC: Direct oral anticoagulants; LMWH: Low molecular weight heparin; RCTs: Randomized controlled trials.
- Citation: Asad D, Abid A, Hassan MB, Nenwani MK, Dev S, Kumar S, Sapna F, Bai P, Siddique S, Jawed I, Alam F, Razzaq FA, C Mekowulu F, Jabeen S, Mirza AM. Direct oral anticoagulants vs LMWH for cancer-associated thrombosis - updated evidence on bleeding risk, recurrence and patient-reported outcomes: A systematic review. World J Methodol 2026; 16(2): 110380
- URL: https://www.wjgnet.com/2222-0682/full/v16/i2/110380.htm
- DOI: https://dx.doi.org/10.5662/wjm.v16.i2.110380
